Addex Therapeutics ADXN
NASDAQ ADXN
$2.96 +0.22 (+8.03%)
At close: Nov 10, 2026 · 4:00 PM EST

Addex Therapeutics (ADXN) Return on Sales [ROS] (2019 - 2026)

Updated

Addex Therapeutics (ADXN) recorded Return on Sales [ROS] of -314218.95% in Q4 2025, down 131526.64 percentage points from -182692.31% a year earlier and down 311876.82 percentage points from the prior quarter.

Analysis

Addex Therapeutics (ADXN) Return on Sales [ROS] (2019 - 2026) Analysis & Trends

For FY2025, Addex Therapeutics reported Return on Sales [ROS] of -9390.76%, down 8708.94 percentage points from FY2024.

  • Annual Return on Sales [ROS] has a five-year change of -9051.87 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -681.82% in FY2024 (-542.76 pp), -139.06% in FY2023 (+601.99 pp), -741.04% in FY2022 (-209.35 pp) and -531.70% in FY2021 (-192.81 pp).
  • The Q4 2025 figure is the lowest quarterly Return on Sales [ROS] in data going back to Q1 2019.
  • On a year-over-year basis, Return on Sales [ROS] has declined for three consecutive quarters, with an average year-over-year change of -45415.16 percentage points over the last seven quarters.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 10893.79 percentage points in Q3 2021, against a drop of 181230.60 percentage points in Q4 2024 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Addex Therapeutics 3.65 Mn -3.31 Mn - -8,739.47%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8,739.47%
Dec 31, 2025 -314,218.95%
Sep 30, 2025 -2,342.13%
Jun 30, 2025 -2,703.87%
Mar 31, 2025 -1,720.53%
Dec 31, 2024 -29,550.80%
Sep 30, 2024 -1,155.71%
Jun 30, 2024 -780.13%
Mar 31, 2024 -337.54%
Dec 31, 2023 -475.65%
Sep 30, 2023 -228.61%
Jun 30, 2023 -403.69%
Mar 31, 2023 -73.40%
Dec 31, 2022 -3,463.70%
Sep 30, 2022 -1,017.78%
Jun 30, 2022 -3,868.04%
Mar 31, 2022 -2,429.04%
Dec 31, 2021 -491.79%
Sep 30, 2021 -524.31%
Jun 30, 2021 -454.03%
API Access

Addex Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ADXN&period=max&api_key=YOUR_API_KEY